Skip to Main Content
CWRU Links

Profiles

Nancy Oleinick, PhD

Nancy Oleinick, PhD

Co-Director, Radiation Resources Core Facility

nlo@case.edu 216.368.1117 (o) 216.368.1142 (f)

Professor, Radiation Oncology
Member, Molecular Oncology Program

Nancy L. Oleinick, PhD is a professor of radiation oncology and the Joseph T. Wearn, MD, University Professor of Medicine. From 1986 to 2013, she was the Director of Radiation Resources Core Facility at Case Comprehensive Cancer Center. From 1986 to 2012, she was the co-director of the Cell Death Regulation Program for CCCC. From 1986 to 1998, she was the director of the Division of Radiation Biology in the Department of Radiology at Case Western Reserve University. Beginning in 1985, she has been a professor of radiology, environmental health sciences, biochemistry, and oncology (1987-present), and oral biology (1985-1991). She is currently the Chief Scientific Officer of Fluence Therapeutics, Inc. since 2010.

Dr. Oleinick earned her BS in chemistry from Chatham College in 1962. She earned her PhD in biochemistry from the University of Pittsburgh in 1966 and earned a post-doctorate degree in biochemistry from Case Western Reserve University in 1968.

View External Profile

View Publications

For many years, Nancy L. Oleinick was director of a program within the Case Comprehensive Cancer Center, which is now part of the Molecular Oncology Program; she was also director and then co-director of the Radiation Resources Core Facility. Dr. Oleinick’s research currently includes studies of ionizing radiation-induced DNA damage and repair, mechanisms of radiosensitization by drug-radiation combinations, photosensitization related to photodynamic therapy, and translation of findings to the development of clinical protocols. Dr. Oleinick’s research currently includes studies of ionizing radiation-induced DNA damage and repair, mechanisms of radiosensitization by drug-radiation combinations, photosensitization related to photodynamic therapy, and translation of findings to the development of clinical protocols. 

molecular oncology, radiation resources, ionizing radiation-induced DNA, DNA damage, radiosensitization,  photosensitization, photodynamic therapy, cancer chemotherapeutics, pemetrexed,methoxyamine, ribonucleotide reductase